Folgen
Beau Kilmer
Beau Kilmer
Director, RAND Drug Policy Research Center
Bestätigte E-Mail-Adresse bei rand.org - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Marijuana legalization: What everyone needs to know®
JP Caulkins, B Kilmer, MAR Kleiman
Oxford University Press, 2016
4142016
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
R Smart, JP Caulkins, B Kilmer, S Davenport, G Midgette
Addiction 112 (12), 2167-2177, 2017
3732017
Developing public health regulations for marijuana: lessons from alcohol and tobacco
RL Pacula, B Kilmer, AC Wagenaar, FJ Chaloupka, JP Caulkins
American Journal of Public Health 104 (6), 2014
3142014
Considering marijuana legalization: Insights for Vermont and other jurisdictions
JP Caulkins, B Kilmer, M Kleiman, RJ MacCoun, G Midgette, P Oglesby, ...
Rand Corporation, 2015
255*2015
Altered state?: assessing how marijuana legalization in California could influence marijuana consumption and public budgets
B Kilmer, JP Caulkins, RL Pacula, RJ MacCoun, P Reuter
RAND, 2010
2042010
Research on drugs-crime linkages: The next generation
R MacCoun, B Kilmer, P Reuter
Toward a drugs and crime research agenda for the 21st century 1, 65-95, 2003
1802003
A framework for synthetic control methods with high-dimensional, micro-level data: evaluating a neighborhood-specific crime intervention
MW Robbins, J Saunders, B Kilmer
Journal of the American Statistical Association 112 (517), 109-126, 2017
1632017
The economic cost of methamphetamine use in the United States, 2005
N Nicosia, RL Pacula, B Kilmer, R Lundberg, J Chiesa
Rand Corporation, 1-171, 2009
1562009
An analysis of applicants presenting to a medical marijuana specialty practice in California
H Nunberg, B Kilmer, RL Pacula, JR Burgdorf
Journal of drug policy analysis 4 (1), 2011
1552011
Efficacy of frequent monitoring with swift, certain, and modest sanctions for violations: Insights from South Dakota’s 24/7 Sobriety Project
B Kilmer, N Nicosia, P Heaton, G Midgette
American Journal of Public Health 103 (1), e37-e43, 2013
1472013
The future of fentanyl and other synthetic opioids
B Pardo, J Taylor, JP Caulkins, B Kilmer, P Reuter, BD Stein
131*2019
Prevalence of cannabis use in youths after legalization in Washington state
JA Dilley, SM Richardson, B Kilmer, RL Pacula, MB Segawa, M Cerdá
JAMA pediatrics 173 (2), 192-193, 2019
1232019
Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19
JP Caulkins, B Kilmer, RJ MacCoun, RL Pacula, P Reuter
Addiction 107 (5), 865-871, 2012
1232012
Risks and prices: The role of user sanctions in marijuana markets
RL Pacula, B Kilmer, M Grossman, FJ Chaloupka
The BE Journal of Economic Analysis & Policy 10 (1), 2010
1162010
Uruguay’s middle-ground approach to cannabis legalization
M Cerdá, B Kilmer
The International journal on drug policy 42, 118, 2017
1122017
What America's Users Spend on Illegal Drugs, 2000-2010
B Kilmer, JP Caulkins, SS Everingham
Rand Corporation, 2014
108*2014
Reducing drug trafficking revenues and violence in Mexico: Would legalizing marijuana in California help?
B Kilmer
RAND International Programs and Drug Policy Research Center, 2010
108*2010
Considering marijuana legalization carefully: insights for other jurisdictions from analysis for Vermont
JP Caulkins, B Kilmer
Addiction 111 (12), 2082-2089, 2016
1072016
Big data on a big new market: Insights from Washington State’s legal cannabis market
JP Caulkins, Y Bao, S Davenport, I Fahli, Y Guo, K Kinnard, M Najewicz, ...
International Journal of Drug Policy 57, 86-94, 2018
1052018
Before the grand opening: Measuring Washington State’s marijuana market in the last year before legalized commercial sales
B Kilmer, JP Caulkins, G Midgette, L Dahlkemper, RJ MacCoun, ...
Rand Corporation, 2013
972013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20